Bennie H. Jeng, MD

I have always been Penn Proud. I was fortunate that I attended medical school here, and I loved it. Rotating at the Scheie Eye Institute as a student in the late 1990s was pivotal in directing me into what I truly believe is the best field in medicine. At that time, Dr. Stuart Fine was leading an amazing group of renowned faculty who excelled in research, education, and clinical care, and I was inspired. But never in my wildest dreams did I ever think that I would be back at Penn 24 years after graduating, and with the opportunity to succeed a long line of luminaries to help lead our department into the future.

Last year’s issue of our annual report was a celebration of both the prior 150 years of our department and of the last 50 years of the Scheie Eye Institute, and these landmark events were expertly and caringly curated by our immediate past chair, Dr. Joan O’Brien, and her team. None of our accomplishments going forward would be possible without the tremendous efforts of those who came before us, so I wanted to take this opportunity to thank all the current and past faculty and staff of the Department for setting us up for success going into the next 150 years!

These last two years have been extremely exciting. We truly have undergone a 360-degree expansion with explosive growth and innovations in our research, clinical, and educational arenas. On the research front, we have developed our SMART—Scheie Mechanisms of Aging and Rejuvenation Therapy—initiative to guide our research efforts at the F.M. Kirby Center, which celebrated its 30th year since its founding in 1994. We have recruited two outstanding basic and translational scientists to join us, adding expertise in transcriptomics and gene editing. In addition, our current scientist and clinician-scientist faculty have continued their successful research programs, securing extensive extramural funding which has contributed to our significant increase in NIH funding this year. We were also fortunate to receive a five-year renewal of our unrestricted grant from Research to Prevent Blindness. Furthermore, we also filled all four of our available K12 scholar slots as we continue our commitment to foster young investigators to start and succeed in research careers.

On the clinical side, our growth in the last two years has been tremendous. To date, we have brought 14 faculty into our family—seven of these new faculty will be starting next year—and we added three satellite offices, with a fourth one coming soon.

Our patient volumes in the clinic have continued to increase year over year, and we are now far above pre-pandemic levels. Our surgical volume has increased by over 50%. We have also secured a commitment in partnership with Penn Medicine to renovate part of our Scheie building to create more clinical space. And we have initiated an aggressive quality and patient safety campaign with the goal of being a national leader in providing the highest quality of patient-centric care.

Our educational programs have also continued to thrive. Our undergraduate medical education program remains outstanding with all 16 students over the last two years matching into top-tier residency programs across the country. Four of our current faculty have appointments in the Dean’s office, which is quite remarkable for a field that is often marginalized at some medical schools. Our residency program continues to attract and match with the brightest, most talented, and diverse students from around the country. This year, we created a research track for our residency called iPOWER, innovative Program in Ophthalmology With Exceptional Research, and we matched for our first resident to start this summer. To go along with our established fellowship programs, we also started a cornea fellowship, with our first fellow also starting this summer. Finally, the past year culminated with the opening of the Measey Surgical Innovations Core at Scheie—MSICS. This state-of-the-art surgical simulation facility is equipped with 11 microscope stations. It is designed for the very best wet lab training, which will greatly enhance our surgical education program and, importantly, result in even better patient outcomes.

With all of these initiatives and innovations, I hope you can see that our department has truly undergone a 360-degree expansion, and I hope that this brief overview has piqued your interest to read more about each of these in this annual report. Please keep in mind that none of this would have been possible without the accomplishments of the past, the hard work and dedication of our current faculty and staff, and the support of Penn Medicine; it is truly a team effort, and I am deeply honored to be a part of this team.

As I noted in the beginning, I have always been Penn Proud—but now, I am and will always be Scheie Proud as well! I hope you enjoy this issue, and I look forward to seeing and hearing from you.

With best regards,

Bennie H. Jeng, MD, MS
Harold G. Scheie Chair and Professor
Director, Scheie Eye Institute
bennie.jeng@pennmedicine.upenn.edu

  • Herbert and Karen Lotman

    A New Home for the Macula Vision Research Foundation

    Scheie Vision Annual Report 2018: The Macula Vision Research Foundation finds a new home at the Scheie Eye Institute.

  • Sheri Grand Drossner and Dr. Ranjoo Prasad

    Scheie's Vision Loss Support Group

    Scheie Vision Annual Report 2018: The Penn Center for Low Vision Rehabilitation's Vision Loss Support Group expands in size and impact.

  • Leaders of an ROP workshop

    Global Connections and Global Impact

    Scheie Vision Annual Report 2018: Dr. Graham Quinn and colleagues create a retinopathy of prematurity workshop program to detect and treat this condition in other countries.

  • Omega-3 supplements

    Fish Oil and Dry Eye

    Scheie Vision Annual Report 2018: A large clinical trial, published in the New England Journal of Medicine, evaluates fish oil as a treatment for dry eye disease.

  • Dr. Shindler sitting at a desk

    Preclinical Studies for Optic Nerve

    Scheie Vision Annual Report 2018: Dr. Kenneth Shindler’s research explores novel methods to prevent damage to the optic nerve.

  • Recipients of the 2018 Antonio Champalimaud Vision Award

    Champalimaud Vision Award

    Scheie Vision Annual Report 2018: Three Penn ophthalmologists receive the António Champalimaud Vision Award for their work leading to the first gene therapy for an inherited disease.

  • Dr. Cesar Briceno and Madhura Tamhankar smiling at the camera

    Scheie Launches Thyroid Eye Disease Program

    Scheie Vision Annual Report 2018: The Scheie Eye Institute creates a program to treat patients with thyroid eye disease.

  • Scheie Building

    New Arrivals 2018

    Scheie Vision Annual Report 2018: The Department of Ophthalmology welcomes its newest faculty members.

  • Plaque Presentation for Gene Therapy

    The Team Making Blind Kids See

    Scheie Vision Summer 2018: Scheie physicians receive FDA approval for Luxturna, the first gene therapy for an inherited disease in the United States.

  • Christian Guardino

    Patient Testimonial: Gene Therapy

    Scheie Vision Summer 2018: Four years after participating in the Phase III clinical trial for gene therapy, Christian Guardino performs on America's Got Talent.

  • Dr. Jessica Morgan

    Next Step in Precision Medicine

    Scheie Vision Summer 2018: Dr. Jessica Morgan's research contributes to future treatments for a range of hereditary retinal diseases.

  • Medication

    Assessing the Risk of Intraocular Bleeding

    Scheie Vision Summer 2018: A new analysis led by Dr. Brian VanderBeek explores the ocular safety profile of novel antithrombotics.

  • doctor looking at patient eye

    Patient Testimonial: Treating Dry Eye at Scheie

    Scheie Vision Summer 2018: Deborah Pley shares her experience with Penn's Dry Eye and Ocular Surface Center.

  • World Map

    Bringing Eye Care Across the World

    Scheie Vision Summer 2018: Dr. Sonul Mehta travels around the world to provide medical care to under-served populations.

  • Lang Lourng Ung

    Faces of Scheie: Ophthalmic Technicians

    Scheie Vision Summer 2018: In ophthalmology clinics, technicians like Lang, play a crucial role in optimizing the quality and efficiency of care.

  • Alumni Event

    144 Years of the Ophthalmology Department

    Scheie Vision Summer 2018: The Department of Ophthalmology celebrates its 144th Anniversary at the Scheie Alumni Meeting this past April.

  • gene therapy illustration

    Milestone for Gene Therapy

    Scheie Vision Annual Report 2017: Drs. Jean Bennett and Al Maguire receive FDA approval for first gene therapy targeting inherited retinal disease.

  • mosquito on skin

    Retinal Damage from Zika

    Scheie Vision Annual Report 2017: Dr. Tomas Aleman studies Zika's effect on retinal development in infants.

  • stacy young with al maguire

    Patient Testimonial: Finding Her Way Out of the Darkness

    Scheie Vision Annual Report 2017: Stacy Young sees hope 17 years after fireworks injury.

  • Drs. Brainard and Aguirre

    Understanding Photophobia

    Scheie Vision Annual Report 2017: Vision scientists investigate function of a third class of light-sensing cells.

  • animated teacher showing students a display

    Art of Diagnosis

    Scheie Vision Annual Report 2017: Penn Medicine takes a creative approach to teaching medical observation.

  • Drs. Vatinee Bunya and Mina Massaro

    The DREAM Study

    Scheie Vision Annual Report 2017: Dr. Vatinee Bunya and colleagues investigate whether Omega-3 fatty acids alleviate symptoms of dry eye disease.

  • CATT_Teaser

    10 Years After the Beginning of CATT

    Scheie Vision Annual Report 2017: Dr. Maureen Maguire describes the history and promise of anti-VEGF drugs for treating AMD.

  • Scheie Residents Group Photo

    Scheie Residency Expands

    Scheie Vision Annual Report 2017: The Ophthalmology Residency has expanded surgical volume in the past few years.

  • Scheie Building exterior

    New Arrivals 2017

    Scheie Vision Annual Report 2017: The Department of Ophthalmology welcomes its newest members.

  • binenbaum examining camera

    Caring for Eyes of All Sizes

    Scheie Vision Summer 2017: Dr. Gil Binenbaum creates algorithm to save tens of thousands of healthy infants from unnecessary retinal exams.

  • Benjamin Kim in front of a piece of equipment

    Retina Research: A Spirit of Collaboration

    Scheie Vision Summer 2017: Dr. Benjamin Kim engages in multiple innovative research programs.

  • Prasad Support Group

    Vision Loss Support Group

    Scheie Vision Summer 2017: Dr. Ranjoo Prasad leads support group for patients with vision loss.

  • Portnoy_WithPatient_Language_Cropped

    Medical Interpretation Services

    Scheie Vision Summer 2017: Penn expands translation services for non-English speaking patients.

  • Briceno_Colombia

    Eye Care in Colombia

    Scheie Vision Summer 2017: Dr. César Briceño provides exams and glasses in remote Amazonian region.

  • Retina Iron

    Does Excess Iron Contribute to AMD?

    Scheie Vision Summer 2016: Dr. Josh Dunaief and colleagues investigate new therapies for slowing AMD progression.

  • Grunwald_Action

    Tracking Kidney Disease in the Retina

    Scheie Vision Summer 2016: Dr. Juan Grunwald and colleagues identify link between retinopathy and chronic kidney disease.

  • faculty_spotlight

    Faculty Spotlights

    Penn ophthalmologists are pioneers in research and in patient care. Learn about the diverse and winding paths that took them to where they are today.

  • Surgery

    Alumni Spotlights

    Graduates of the Penn Ophthalmology residency and fellowship programs become leaders in research, patient care, and teaching. Check out the latest news with these alumni.

Share This Page: